The company Boehringer Ingelheim is continuing its support for the Gutenberg Health Study (GHS) with a sum of three million Euros by the end of 2017. …
Göttingen pharmacologists led by DZHK - scientist Prof. Dr. Ali El - Armouche explore new therapy for heart failure: they activate the heart’s…
Scientific know-how and skills of external partners are sought after in the German Centre for Cardiovascular Research (DZHK). Therefore it is now…
